Johnson & Johnson (JNJ) Tops Q1 EPS by 18c; Raises Outlook

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.68, $0.18 better than the analyst estimate of $2.50. Revenue for the quarter came in at $24.7 billion versus the consensus estimate of $23.61 billion.

GUIDANCE:

Johnson & Johnson sees FY2023 EPS of $10.60-$10.70, versus the consensus of $10.51. Johnson & Johnson sees FY2023 revenue of $97.9-98.9 billion, versus the consensus of $97.71 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• Zscaler shares slip following conservative annual billings guidance
• These 10 leading companies talked about AI the most on their earnings calls
• Zscaler (ZS) Tops Q1 EPS by 18c, Offers Guidance